EMAIL THIS PAGE TO A FRIEND

Cell

Breast cancer stem cells: eradication by differentiation therapy?


PMID 19703390

Abstract

During metastasis, migrating breast cancer stem cells undergo a loss of polarity leading to an epithelial-to-mesenchymal transition (EMT). Gupta et al. (2009) use this attribute of cancer stem cells to develop a high-throughput screen, which successfully identifies small molecules that specifically inhibit cancer stem cell proliferation through the induction of differentiation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

S6201
Salinomycin, Ready Made Solution, from Streptomyces albus, ≥98% (HPLC)
C42H70O11